Loading...

Genomma Lab Internacional, S.A.B. de C.V.

GNMLFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.09
$0.00(0.00%)

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Company Profile & Overview

Explore Genomma Lab Internacional, S.A.B. de C.V.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Company Profile & Overview

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOJuan Marco Sparvieri

Contact Information

52 55 5081 0000
Av. Antonio Dovalí Jaime no.70, Mexico City, DF, 01210

Company Facts

1,605 Employees
IPO DateMay 4, 2012
CountryMX
Actively Trading

Frequently Asked Questions

;